Testing and Resources for CCMV
Congenital cytomegalovirus (cCMV)
Congenital cytomegalovirus (cCMV) is a condition that occurs when CMV crosses the placenta during pregnancy and infects the fetus.¹ cCMV affects about 1 in 200 infants, and around 1 in 5 babies born with cCMV will have long-term health problems.² For newborns less than 21 days old with possible cCMV or maternal CMV exposure, early screening by Labcorp using DiaSorin Molecular's FDA-cleared Simplexa Congenital CMV Direct PCR urine and saliva test can help you start treatment earlier to reduce or prevent long-term complications.